Trial Profile
Phase I study of RX-0201 in patients with advanced or metastatic solid tumors
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 24 Oct 2006
Price :
$35
*
At a glance
- Drugs RX 0201 (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 24 Oct 2006 Status change
- 01 Mar 2006 New trial record.